{'hepatitis': {'farnesyl transferase inhibitor ( farnesyl transferase inhibitor': 1, 'lonafarnib': 1, 'farnesyl transferase inhibitor': 2, '28,525': 1, 'immunoglobulin': 1, 'mesalazine': 2, 'red blood cells ( red blood cells': 1, 'tenofovir': 2, 'tenofovir prodrug': 1, 'tenofovir disoproxil fumarate ( tenofovir-disoproxil-fumarate': 1, 'entecavir': 18, 'nucleoside analogs': 1, 'sofosbuvir': 4, 'nucleoside analogs target the rna - dependent rna polymerase ( rna-dependent rna polymerase )': 1, 'nucleoside analogs as inhibitors': 1, 'mrnas': 1, 'fresh frozen plasma ( fresh frozen plasma )': 1, 'red cell component composed': 1, 'fresh frozen plasma composed': 1, 'jak1': 1, 'telbivudine': 1, 'lamivudine': 2, 'tetraspanins': 2, 'zonula': 2, 'phbx': 2, 'nucleos(t)ide analogs ( nucleos(t)ide analogs )': 1, 'nucleos(t)ide analogs antiviral therapy will still develop low - level viremia ( level viremia )': 1, 'nucleos(t)ide analogue antiviral therapy . with the advancement of polymerase chain reaction technology': 1, 'nucleos(t)ide analogs such': 1, 'tenofovir disoproxil fumarate': 4, 'tenofovir alafenamide fumarate can inhibit virus (hcv replication': 1, 'polio vaccine': 1, 'polio vaccine )': 1, 'antihistamines': 4, 'amino acid': 1, 'fadv.liver': 1, 'antibiotic': 9, 'antibiotics': 3, 'pentavalent': 2, 'steroids': 1, 'prednisolone': 4, 'mxene': 1, 'pgrna': 3, 'tamoxifen': 2, 'serm compounds': 1, 'pharmacokinetics': 1, 'platelets': 1, 'hydrogen peroxide': 1, 'chemotherapy': 8, 'capecitabine': 2, 'serotonin reuptake inhibitors ( selective serotonin reuptake inhibitors )': 1, 'ssri': 5, 'serotonin reuptake inhibitors': 2, 'antivirals': 4, 'nucleosides': 1, 'lipemia': 3, 'pegylated interferon - alpha ( peg - infalpha': 1, 'nucleos(t)ide analogues': 1, 'nucleos(t)ide analogues . inflammation is generally considered a key risk factor in the progress of several chronic diseases , such as': 1, 'spondylarthritis': 5, 'nitric oxide ( nitric oxide': 1, 'e)-9': 2, 'nitric oxide': 1, 'chitinase': 4, 'youden': 1, 'perflubutane': 1, 'contrast': 1, '18,298': 1, 'polio vaccine ( opv zero dose': 1, 'psychinfo': 1, 'lpc(18:0': 1, 'isocaproic acid': 1, 'taurocholic acid': 1, 'meropenem': 1, 'heteroaryldihydropyrimidine compounds ( heteroaryldihydropyrimidine compounds )': 1, 'heteroaryldihydropyrimidine compounds': 1, 'corticosteroids': 1, 'rituximab': 1, 'nonsteroidal': 1, 'ceftazidime': 1, 'cefepime': 1, 'interferon alpha / peginterferon alpha ( ifnalpha / peg - ifnalpha )': 1, 'nonselective beta - blockers ( or = 0.294': 1, 'blood': 1, 'velpatasvir': 1, 'nucleotide analogs (': 1, 'methadone': 1, 'glecaprevir': 1, 'pembrolizumab': 5, 'biopharmaceutics': 1, 'verapamil': 3, 'coculture': 1, 'fibrogenesis': 2, 'hyaluronic acid ( hyaluronic acid': 1, 'hyaluronic acid': 1, 'biodegradable synthetic polymeric': 1, 'il-2': 1, 'ifn': 1, 'egf': 1, 'opioid': 11, 'prescription opioid exposure status ( long - term vs prescription opioid - naive / acute )': 1, 'morphine': 2, 'electrochemiluminescence': 1, 'flavonoid silymarin': 1, 'amanita': 1, 'anticancer': 1, 'silymarin compounds': 1, 'gentamicin': 1, 'antimicrobials': 2, 'ampicillin': 1, 'amoxicillin': 1, 'trimethoprim': 1, 'sulfamethoxazole': 1, 'saudi': 1, 'arabia': 1, 'nicotinamide adenine dinucleotide ( nicotinamide adenine dinucleotide )': 1, 'nad+': 1, 'nicotinamide adenine dinucleotide ( nadh )': 1, 'nicotinamide adenine dinucleotide levels declined in skeletal muscle in association with human immunodeficiency virus infection and was exacerbated by hepatitis c virus (hcv and cytomegalovirus coinfection': 1, 'nicotinamide adenine dinucleotide': 2, 'coinfections': 1, 'nicotinamide adenine dinucleotide metabolites in skeletal muscle in association with viral coinfection': 1, 'pathogeneses': 1, 'tcell': 1, 'particulate adjuvants': 1, 'plasmacytic': 1, 'intrasarcoplasmic protozoa immunoreactive with anti - toxoplasma gondii antisera on immunohistochemistry . the protozoa were ultrastructurally confirmed as t. gondii by transmission electron microscopy': 1}, 'hepatitis b': {'28,525': 1, 'immunoglobulin': 2, 'tenofovir': 4, 'tenofovir prodrug': 1, 'tenofovir disoproxil fumarate ( tenofovir-disoproxil-fumarate': 1, 'entecavir': 21, 'fresh frozen plasma ( fresh frozen plasma )': 1, 'red cell component composed': 1, 'fresh frozen plasma composed': 1, 'telbivudine': 1, 'lamivudine': 4, 'zonula': 2, 'phbx': 2, 'nucleos(t)ide analogs ( nucleos(t)ide analogs )': 1, 'nucleos(t)ide analogs antiviral therapy will still develop low - level viremia ( level viremia )': 1, 'nucleos(t)ide analogue antiviral therapy . with the advancement of polymerase chain reaction technology': 1, 'nucleos(t)ide analogs such': 1, 'tenofovir disoproxil fumarate': 4, 'tenofovir alafenamide fumarate can inhibit virus (hcv replication': 1, 'polio vaccine': 1, 'polio vaccine )': 1, 'antihistamines': 3, 'pentavalent': 2, 'mxene': 1, 'pgrna': 3, 'pharmacokinetics': 1, 'hydrogen peroxide': 2, 'chemotherapy': 12, 'capecitabine': 2, 'pegylated interferon - alpha ( peg - infalpha': 1, 'nucleos(t)ide analogues': 1, 'nucleos(t)ide analogues . aims : hepatitis b virus ( hepatitis b virus ) infection is the major risk difference (rd factor for hepatocellular carcinoma ( hepatocellular carcinoma ) in east asia . here we aimed to further investigate the abundance of viral antigen and deoxyribonucleic acid within hepatitis b virus - related hepatocellular carcinoma and surrounding tissues at histological level . method : in addition to routine histopathology , in situ hybridization ( in situ hybridization )': 1, 'polio vaccine ( opv zero dose': 1, 'psychinfo': 1, 'heteroaryldihydropyrimidine compounds ( heteroaryldihydropyrimidine compounds )': 1, 'heteroaryldihydropyrimidine compounds': 1, 'rheumatoid': 1, 'spondylarthritis': 9, 'rituximab': 1, 'nonsteroidal': 2, 'antibiotic': 3, 'ceftazidime': 2, 'cefepime': 1, 'interferon alpha / peginterferon alpha ( ifnalpha / peg - ifnalpha )': 1, 'blood': 1, 'nucleotide analogs (': 1, 'deoxyribonucleic acid aptamers': 1, 'deoxyribonucleic acid aptamer': 2, 'deoxyribonucleic acid processivity': 1, 'coculture': 1, 'fibrogenesis': 2, 'biodegradable synthetic polymeric': 1, 'il-2': 3, 'ifn': 2, 'egf': 1, 'pathogeneses': 1, 'particulate adjuvants': 1, 'aluminum hydroxide adjuvant': 1, 'steroids': 2, 'cyclophosphamide': 1, 'packed red blood cells': 1, 'immunosuppressive': 2, 'iodine': 1, 'mdsc': 2, 'chop': 1, 'nucleos(t)ide analogue therapy . we assessed the associations of clinical factors , including soluble immune checkpoint proteins': 1, 'carboplatin': 1, 'paclitaxel': 1, 'tenofovir disoproxil fumarate ( tenofovir-disoproxil-fumarate )': 1, 'gemmiger': 2, 'phascolarctobacterium': 1, 'fatty acid': 1, 'palmitoylcarnitine': 1, 'nomogram': 1, 'crispr': 4, 'checkpoint inhibitors': 1, 'hccs': 2, 'coexpression': 1, 'pcv': 1, 'bile acid uptake': 1, 'nucleos(t)ide analogues ( nucleos(t)ide analogue )': 1, 'nucleos(t)ide analogue therapy , several efforts have been made to develop therapeutic monoclonal antibodies with neutralizing activity against hbs antigens . however , the neutralizing effect of these monoclonal antibodies may be muted by a large excess of hepatitis b surface antigen - positive noninfectious particles in the blood of infected patients . the advantage of na(+)/taurocholate cotransporting polypeptide - targeted hepatitis b virus entry inhibitors is that they remain effective regardless of viral genotype , viral mutations and the presence of subviral particles': 1, 'myrcludex': 1, 'cycloaddition': 2, 'mycophenolic acid': 1, 'valganciclovir': 1, 'phosphoseryl': 2, 'phosphoseryl-trna kinase': 1, 'trna kinase inhibitor': 1, 'phosphoseryl-trna kinase inhibitors': 1, 'zanalyzed': 1, 'tacrolimus': 2, 'mycophenolate mofetil': 2, 'rapamycin': 1, 'electrochemiluminescence': 3, 'pharmacokinetic': 1, 'methylmalonic': 1, 'chemoembolization': 1, 'analgesics': 1, 'immunosuppressive agents': 1, 'immunoblotting': 1, 'nbnc': 2, 'antidepressants': 1, 'antivirals': 1, 'embase': 1, 'scopus': 1, 'analogue': 1, 'platelet': 1, 'helsinki': 1, 'istanbul': 1, 'etoposide': 4, 'pmea': 1, 'cidofovir': 1, 'ganciclovir': 1, 'tlr8 agonist selgantolimod ( selgantolimod )': 1, 'pdcs': 1, 'mait cells': 1, 'selgantolimod': 1, 'opioids': 2}, 'hepatocellular carcinoma': {'heparin sulfate': 1, 'magl': 1, 'chemokine ligand': 1, 'monocarboxylate transporter': 1, 'palmitate acid (oa ( palmitate acid': 1, 'palmitate acid (oa - treated': 1, 'sorafenib': 34, 'lenvatinib': 10, 'nod2': 1, 'pyroptosis': 1, 'purine nucleoside monophosphate metabolic process': 1, 'ici': 1, 'clinicopathological': 2, 'adrenergic agonist': 1, 'analgesia': 1, 'sedation': 1, 'chemotherapy': 9, 'cisplatin': 3, 'interactions': 1, 'lysates': 1, '17 k': 1, 'zonula': 2, 'phbx': 2, 'imatinib': 1, 'immunochemotherapy': 1, 'atezolizumab': 5, 'bevacizumab': 5, 'transarterial': 4, 'immunoblotting': 2, 'antihistamines': 3, 'versican': 1, 'maximisation': 2, 'immunohistochemical': 1, 'solamargine': 10, 'anticancer': 4, 'mechanistically': 1, 'tug1': 2, 'hepg2': 1, 'serotonin reuptake inhibitors ( selective serotonin reuptake inhibitors )': 1, 'ssri': 5, 'serotonin reuptake inhibitors': 2, 'carboplatin': 1, 'doxorubicin': 6, 'fluorouracil': 1, 'gemcitabine': 2, '2clibmeca': 1, 'a3arspecific': 1, 'cathelicidin': 1, 'smmc-7721': 1, 'characterising': 1, 'arv': 1, 'galarv': 1, 'fish oil': 3, 'chemoembolization': 1, 'mrnas': 1, "tyrosine kinase inhibitors and/or immunotherapy seem to be the future , depending on the molecular profile of each patient 's tumor . hepatocellular cholangiocarcinoma [cca] ( hepatocellular carcinoma )": 1, 'phenyl benzoate linker in bdp - l - camptothecin': 1, 'camptothecin': 1, 'srting': 1, 'cytoscape': 2, 'ppi': 1, 'chitinase': 4, 'youden': 1, 'free arsenic trioxide ( arsenic trioxide )': 1, 'free arsenic trioxide , arsenic-loaded zeolitic imidazolate framework-8 nanoparticles': 1, 'chemoprotective': 1, 'aspirin': 12, 'cochrane': 1, 'nanocarrier': 2, 'paclitaxel': 6, 'zosuquidar': 4, 'free': 1, 'pro - agiogenic proteins': 1, 'regulate reticulon': 1, 'exo1': 1, 'gadolinium ethoxybenzyl diethylenetriamine penta - acetic acid (oa ( gd - eob - dtpa)-based contrast agent increases its diagnostic value . histologic confirmation is always required': 1, 'antibiotic': 3, 'ceftazidime': 2, 'cefepime': 1, 'oxygen': 1, 'gbms': 1, 'psycinfo': 1, 'choline': 1, 'tpa': 1, 'circrna': 1, 'ctd': 1, 'oleic acid': 1, 'hccs': 2, 'pretransplant': 1, 'statins': 2, 'statin': 2, 'estrogen receptor alpha ( eralpha , esr1 )': 1, 'eralpha': 2, 'amoeboidal': 1, 'hyaluronic acid (oa ( hyaluronic acid': 1, 'hyaluronic acid': 9, 'biodegradable synthetic polymeric': 1, 'il-2': 1, 'ifn': 1, 'egf': 1, 'disodium': 2, 'magnetite folate core shell ( magnetite folate core shell': 1, 'alanine amino transferases': 1, 'magnetite folate core shell': 1, 'palmitic acid (oa ( palmitate acid': 1, 'oleic acid (oa ( oleic acid )': 1, 'ampk': 1, 'ampk agonist': 1, 'palmitate acid fragment': 1, 'diphenyltetrazolium bromide ( mtt )': 1, 'intratumoral': 1, 'unresectable hyaluronic acid ( 31.7': 1, 'fgf21': 1, 'fgf23': 1, 'microg': 1, 'pegylated': 1, 'curcumin': 1, 'pair curcumin': 1, 'vitamin k absence or antagonist - ii ( pivka - ii ) ( pivka - ii - fibrosis-4': 1, 'pathogeneses': 1}, 'tumor': {'folfirinox': 1, 'immunoglobulin': 1, 'methylprednisolone': 1, 'somatostatin': 1, 'bisphosphonates': 1, 'denosumab': 1, 'actinomyces': 4, 'chemotherapy': 36, 'rapamycin': 5, 'pancreaticoduodenectomy': 2, 'linifanib': 1, 'hdac': 1, 'chemo': 1, 'interleukin-2': 61, 'il-2': 56, 'docetaxel': 5, 'gemcitabine': 1, 'nab - paclitaxel against b16f10': 1, 'covalent inhibitor': 1, 'gsh': 1, 'kg(-1': 2, 'astragalus polysaccharides ; eb :': 1, 'astragalus polysaccharides': 1, 'astragalus polysaccharides )': 1, 'catla': 2, 'catla catla )': 1, 'albumin': 1, 'malondialdehyde': 1, 'glutathione peroxidase ( glutathione peroxidase': 1, 'nitric oxide synthase ( nitric oxide synthase )': 1, 'hydrogen peroxides ( h2o2 )': 1, 'astragalus polysaccharides diets on week': 1, 'astragalus polysaccharides enriched diets revealed significant improved tumor necrosis factor ( tnf)-alpha and tumor necrosis factor receptor - associated factor-6 ( tnf receptor-associated factor-6 ) mrna expression on week': 1, 'paclitaxel': 6, 'praziquantel': 1, 'pd-1': 1, 'pemetrexed': 1, 'cisplatin': 5, 'mek inhibitor ( mek inhibitor': 1, 'mek inhibitor / anti - pancreaticoduodenectomy - l1 therapy (pdt': 1, 'optn': 1, 'photothermal': 6, 'aecii': 1, 'spirulina': 2, 'atezolizumab': 1, 'akt inhibitor': 1, 'foundationone': 1, 'taxane': 2, 'cobas': 1, 'osimertinib': 1, 'fluorouracil': 1, 'leucovorin': 1, 'irinotecan': 8, 'oxaliplatin': 1, 'serine hydrolase carboxylesterase': 1, 'pdgfra': 1, 'nctn': 1, 'amino acid ( amino acid': 1, 'amino acid': 5, 'o2': 1, 'mineral nanomedicine': 1, 'europium - doped calcium fluoride': 1, 'electrodynamic': 2, 'zeolite imidazole': 1, 'single amino acid mutations': 1, 'mmp8': 1, 'eotaxin': 1, 'tgfrbeta': 1, 'mmp2': 1, 'phosphodiesterase-5 inhibitors': 1, 'metformin': 11, 'neoadjuvant immunotherapy': 1, 'nivolumab': 1, 'ipilimumab': 2, 'pembrolizumab': 5, 'beta - hydroxybutyrate ( beta-hydroxybutyrate )': 1, 'fatty acid': 4, 'insulin': 3, 'beta-hydroxybutyrate': 1, 'quantitative insulin sensitivity check index rquicki - beta-hydroxybutyrate': 1, 'suvmean': 1, 'kaempferol': 1, 'ascorbic acid': 1, 'fatty acids': 1, 'hexadecenoic acid': 1, 'il-2 hydroxy octadecanoic acid': 1, 'dienes': 1, 'phytosphingosine': 1, 'doxorubicin': 3, 'ceramide b ( 2 )': 2, 'sertoliomas': 1, 'aprepitant': 1, 'clinicopathological': 2, 'heparin': 1, 'poloxamer': 1, 'curcuminoid': 2, 'nanogels': 2, 'curcumin': 2, 'annexin': 1, 'p38 inhibitor': 1, 'jnk inhibitor': 1, 'pklr': 1, 'furosemide': 3, 'cimetidine': 2, 'para - amino hippuric acid': 1, 'saline': 1, 'oat inhibitor': 1, 'superoxide dismutase': 1, 'lavage': 3, 'conatumumab': 1, 'quercetin': 1, 'glucocorticoid receptor interactions in normal tissues and tumor is crucial': 1, 'glucocorticoid receptor antagonists ru486 ( mifepristone )': 1, 'dexamethasone': 1, 'antagonist': 1, 'glucocorticoid receptor interactions can be measured in vivo with (': 1, 'glucocorticoid receptor antagonists': 1, 'c5ar antagonist blocked': 1, 'ductal': 2, 'acinar': 1, 'clonally': 1, 'uracil': 1, 'cytarabine': 1, "1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide ( 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide )": 1, "1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide": 1, 'mir-133b': 7, 'wilcoxon': 1, 'shrewd immunohistochemical': 1, 'anisole': 1, 'receptor alpha immunohistochemical expression .': 1, 'receptor alpha immunohistochemical expression , respectively . thus , enhancer of zeste homolog 2': 1, 'tfeb': 2, 'intratumoral': 1, 'beta receptor (': 1, 'beta receptor )': 1, 'beta receptor in': 1, 'beta receptor': 1, 'lymphotoxin': 1, 'beta receptor activated the non - canonical nf - kappab signaling pathway in nih3t3 cells': 1, 'lymphotoxin-beta receptor - nih3t3 cells': 1, 'beta receptor - nih3t3 cells': 1, 'lumbosacral': 1, 'lactic acid bacteria ( lactic acid bacteria )': 1, 'lactic acid bacteria': 1, 'streptozotocin': 4, 'curcumin nanoparticles ( curcumin nanoparticles': 1, 'nitric oxide ( nitric oxide': 1, 'curcumin nanoparticles': 1, 'immunoblotting': 1, 'sorafenib': 9, 'lenvatinib': 6}, 'pain': {'opioids': 16, 'opioid': 32, 'cochrane llibrary': 1, 'analgesia': 16, 'baclofen': 7, 'lpb': 1, 'morphine': 8, 'pharmacokinetics': 1, 'chemoradiotherapy': 4, 'carboplatin': 3, 'paclitaxel': 2, 'trametinib': 2, '-1/1/2/3': 1, 'vrs': 17, 'corticosteroids': 7, 'corticosteroid': 4, 'steroid': 11, 'concomitantly': 2, 'oswestry': 1, 'interlaminar': 2, 'osteonecrosis': 1, 'visual analog scale ( visual analog scale': 1, 'gabapentin': 4, 'psychiatric medication': 1, 'stimwave': 1, 'methylene blue ( methylene blue )': 1, 'nitric oxide synthesis': 2, 'analgesic': 15, 'methylene blue': 2, 'methylene blue group included 53 patients . in both groups , the numeric rating scale': 1, 'methylene blue group were also respective significantly lower than that of the control group at 3 months': 1, 'methylene blue injection': 1, 'methylene blue can significantly reduce pain intensity , improve patient lumbar function: p = 0.018': 1, 'lidocaine': 5, 'diazepam': 6, 'ultrasonographic': 1, 'antihistamines': 1, 'botulinum toxin injection': 2, 'botulinum toxin injections': 1, 'cgx': 1, 'syngeneic': 1, 'proquest': 1, 'nitrous': 2, 'interactions': 1, 'oxygen': 1, 'n2o': 1, 'emono': 3, 'weierkang': 1, 'endotheliitis': 1, 'benzodiazepine': 2, 'nonsteroidal': 2, 'colchicine': 1, 'chemotherapy': 11, 'ccrt': 1, 'cisplatin': 1, 'narcotic analgesics': 1, 'spasmolytics': 1, 'analgesics': 2, 'antibiotics': 4, 'methylene blue dye ( 1.25 ml': 1, 'irinotecan': 1, 'cbdca': 3, 'fentanyl': 3, 'transmucosal': 2, 'curcuma longa ( curcumin )': 1, 'mefenamic': 1, 'mefenamic acid': 2, 'curcumin': 2, 'mefenamic acid (': 1, 'antibiotic': 1, 'amoxicillin': 1, 'metronidazole': 1, 'tongsayobang': 2, 'heparin': 1, 'warfarin': 1, 'vitamin k antagonist': 1, 'anticoagulation': 1, 'albumin': 1, 'glucocorticoid': 1, 'platelet rich plasma ( platelet rich plasma )': 1, 'pf.background': 1, 'remimazolam': 2, 'benzodiazepines': 1, 'propofol': 6, 'propionate receptor antagonists': 1, 'propionate receptor antagonist': 1, 'pregabalin': 6, 'tramadol': 6, 'acetaminophen': 1, 'nortriptyline': 1, 'prednisolone': 1, 'perampanel': 2, 'arabia': 1, 'duloxetine': 1, 'amitriptyline': 1, 'etomidate': 4, 'intraperitoneally': 1, 'detortion': 1, 'buprenorphine': 16, 'methadone': 1, 'iqr': 3, 'progestin': 5, 'levonorgestrel': 1, 'glucocorticoids': 1, 'firmicutes': 2, 'bacteroidetes': 2, 'osaka': 1, 'tetrodotoxin': 1, 'glutamate': 2, 'serratiopeptidase': 3, 'dexamethasone': 3, 'chymotrypsin': 1, 'opioid analgesic dipeptide': 1, 'versius': 1, 'cannabis': 1, 'wilcoxon': 2, 'lysine': 1, 'methionine': 1, 'sedative medications': 1, 'chronic opioid': 1, 'chronic opioid administration': 1, 'contrast': 1, 'diclofenac': 7, 'pain medication': 1, 'chemoradiation': 1, 'intracerebroventricular': 1, 'cysteine protease': 1, 'amantadine': 1, 'selegiline': 1, 'levodopa': 2, 'benserazide': 1, 'carbidopa': 1, 'genecards': 1, 'tamoxifen': 1, 'synovectomy': 1, 'suboxone': 3, 'naloxone': 1, 'sandoz': 1, 'alvogen': 1, 'ropivacaine': 1, 'sufentanil': 1}, 'chronic hepatitis b': {'immunoglobulin': 4, 'tenofovir': 46, 'tenofovir prodrug': 1, 'tenofovir disoproxil fumarate ( tenofovir disoproxil fumarate )': 6, 'entecavir': 61, 'nucleos(t)ide analogs ( nucleos(t)ide analogs )': 1, 'nucleos(t)ide analogs antiviral therapy will still develop low - level viremia ( level viremia )': 1, 'nucleos(t)ide analogue antiviral therapy . with the advancement of pcr technology': 1, 'nucleos(t)ide analogs such': 1, 'tenofovir disoproxil fumarate': 31, 'tenofovir alafenamide fumarate can inhibit virus replication to a certain extent , delay or prevent disease progression , and reduce the incidence of hepatitis b - related liver cancer , but in clinical practice , hepatitis b virus dna positivity is still detected continuously or intermittently in the serum of some patients . therefore , low - level viremia': 1, 'pharmacokinetics': 1, 'pegylated interferon - alpha ( peg - infalpha': 1, 'nucleos(t)ide analogues': 2, 'antibiotic': 3, 'ceftazidime': 2, 'cefepime': 1, 'nucleotide analogs (': 1, 'chemotherapy': 2, 'egf': 1, 'packed red blood cells': 1, 'mdsc': 2, 'il-2': 2, 'ifn': 1, 'nucleos(t)ide analogue therapy . we assessed the associations of clinical factors , including soluble immune checkpoint proteins': 1, 'tenofovir disoproxil fumarate ( n=64': 1, 'checkpoint inhibitors': 1, 'hccs': 1, 'bile acid uptake': 1, 'nucleos(t)ide analogues ( nucleos(t)ide analogue )': 1, 'nucleos(t)ide analogue therapy , several efforts have been made to develop therapeutic mabs with neutralizing activity against hbs antigens . however , the neutralizing effect of these mabs may be muted by a large excess of hepatitis b surface antigen - positive noninfectious particles in the blood of infected patients . the advantage of na(+)/taurocholate cotransporting polypeptide - targeted hepatitis b virus entry inhibitors is that they remain effective regardless of viral genotype , viral mutations and the presence of subviral particles': 1, 'myrcludex': 1, 'tacrolimus': 2, 'mycophenolate mofetil': 2, 'rapamycin': 1, 'pharmacokinetic': 1, 'antidepressants': 1, 'analogue': 1, 'platelet': 1, 'tlr8 agonist selgantolimod ( selgantolimod )': 1, 'pdcs': 1, 'mait cells': 1, 'selgantolimod': 1, 'precore': 1, 'nucleic acid polymers': 1, 'immunosuppressive': 1, 'carboxylesterase': 1, 'nucleos(t)ide analogues ( nucleos(t)ide analogs )': 3, 'nucleos(t)ide analogue therapy in march 2007 at peking university first hospital ( china )': 1, 'lamivudine': 8, 'adefovir': 1, 'pegylated': 4, 'fluconazole': 1, 'bicyclol': 1, 'nucleos(t)ide analogue ( nuc ) therapies to prevent the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis b ( chronic hepatitis b )': 1, 'aucs': 1, 'nomogram': 4, 'immunoprophylaxis': 1, 'interferon - alpha ( ifn - alpha )': 1, 'nucleos(t)ide analogs )': 1, 'interferons ( interferons )': 1, 'nucleos(t)ide analogs effectively suppress hepatitis b virus replication , and interferons improve serological response rates , thereby decreasing the risk of adverse outcomes . however , their efficacy in attaining serological responses , especially functional cure ( i.e. , loss of serum hepatitis b surface antigen )': 1, 'antivirals': 2, 'karonudib': 1, 'tenofovir disoproxil fumarate in chinese patients with chronic hepatitis b ( chronic hepatitis b )': 1, 'nucleos(t)ide analogs ( serum hepatitis b virus dna > 200 iu / ml': 1, 'nucleos(t)ide analogs treatment failure with no new safety findings . background and aims : scarce data exist on the effect of nucleos(t)ide analogue ( nucleos(t)ide analogue': 1, 'nucleos(t)ide analogs': 5, 'nucleos(t)ide analogue': 1, 'nucleos(t)ide analogs . in an attempt to improve vaccine immunogenicity , several techniques have been used , including codon / promoter optimization , coadministration of cytokine adjuvants , plasmids engineered': 1, 'nivolumab': 2, 'azospirillum': 1, 'firmicutes': 1, 'bacteroidetes': 1, 'testosterone': 1, 'dehydroepiandrosterone sulfate': 1, 'hormone binding globulin and free testosterone index were associated with increased stage ( of hepatitis b virus - acute-on-chronic liver failure , ascites , and hepatic encephalopathy )': 1, "nucleos(t)ide analogues ( nucleos(t)ide analogs ) treatment on patient 's clinical outcomes were analyzed . for multivariate analysis , a binary logistic regression model was performed . log - rank test was used to compare the cumulative incidence of hepatocellular carcinoma ( hbv.hepatocellular carcinoma ) in nucleos(t)ide analogs - treated and non - nucleos(t)ide analogue streated patients . results : baseline liver histology status showed that 58.6 % ( 58/99 ) patients had obvious liver tissue damage in their baseline liver tissue pathology ( g>/=2 and /or s>/=2 )": 1, 'nucleos(t)ide analogs treatment': 1, 'nucleoside analogues ( nucleos(t)ide analogs )': 1, 'peginterferon alpha , can only achieve satisfactory results when liver inflammation is active . therefore , international authoritative guidelines recommend hepatitis b virus dna positive and alanine aminotransferase': 1, 'interferon alpha ( interferon alpha )': 1, 'hydroxyurea': 1, 'amino acid metabolism': 1, 'plasma amino acid profiles': 1, 'plasma amino acid': 1, 'arginine': 1, 'methionine': 1, 'aromatic amino acids (aaa ( aromatic amino acids )': 1, 'granulysin': 7, 'nucleos(t)ide analogs ( nucleos(t)ide analogs ) in patients with chronic hepatitis b ( chronic hepatitis b )': 1, 'pegifnalpha': 2, 'nucleos(t)ide analogs ) in four phase': 1, 'pegylated interferon alpha ( peg - ifn - a )': 1, 'rituximab': 3, 'isoagglutinin': 1, 'nucleos(t)ide analogs - resistant mutants in rt region and immune - escape mutants in core and pres2 regions': 1, 'il-8': 2, 'l37q': 1, 'tenofovir disoproxil fumarate ( n = 2482 )': 1, 'adenosylhomocysteinase': 1, 'tenofovir disoproxil fumarate ( tenofovir disoproxil fumarate': 1, 'tenofovir disoproxil fumarate ( 19 patients )': 1, 'embase': 1, 'ihcs': 1, 'vitamin k absence - ii ( pivka - ii': 1, 'alpha - fetoprotein ( alpha-fetoprotein )': 1, 'insulin': 1, 'nucleotide analogues': 1, 'hbvcircle': 1, 'crispr': 2}, 'breast cancer': {'bisphosphonates': 1, 'denosumab': 1, 'actinomyces': 4, 'chemotherapy': 57, 'estradiol': 8, 'testosterone': 1, 'progesterone': 2, 'akt inhibitor': 1, 'paclitaxel': 8, 'foundationone': 1, 'pupose': 1, 'multitesting': 1, 'msh6': 1, 'msh2': 1, 'amino acid ( amino acid': 1, 'amino acid': 5, 'deregulation': 1, 'kaempferol': 1, 'ascorbic acid': 1, 'tamoxifen': 34, 'hydroethanolic': 2, 'nitric oxide': 1, 'malondialdehyde': 9, 'glutathione peroxidase ( gsh - px )': 1, 'trastuzumab': 14, 'heparin': 1, 'poloxamer': 1, 'curcuminoid': 2, 'cisplatin': 4, 'nanogels': 2, 'curcumin': 7, 'anticancer': 3, 'glutathione ( gsh )': 1, 'superoxide dismutase ( superoxide dismutase )': 1, 'doxorubicin': 11, 'ovulation': 1, 'letrozole': 12, 'clomiphene citrate': 3, 'clomiphene': 6, 'livebirth': 5, 'takeda': 1, 'roche': 1, 'estrogen receptor / progesterone receptor / human epidermal growth factor receptor': 1, 'fasting insulin': 2, 'insulin': 3, 'antineoplastic': 1, 'suramin': 3, 'suramin compound derivatives synthesized herein show potential as novel therapeutic agents for their anti - proliferative activity via': 1, 'suramin compound': 1, 'ursolic acid ( ursolic acid': 1, 'ursolic acid': 6, 'artemisinin': 1, 'dihydroartemisinin': 3, 'neoadjuvant chemotherapy': 8, 'parp inhibitor': 1, 'parp inhibitors': 1, 'tumourectomy': 1, 'hormonotherapy': 1, 'compound kushen': 2, 'chemotherapies': 1, 'nomogram': 1, 'crispr': 2, 'progesterone receptor (pr ( progesterone receptor )': 2, 'estrogen receptor': 3, 'herceptin': 14, 'dimerization blocker , stattic ( s )': 1, 'nanocarrier': 1, 'stattic': 5, 'plga nanoparticles': 1, "progesterone receptor (pr status . rates of high wilms' tumor 1-associated protein expression were 66.1": 1, 'abemaciclib': 3, 'steroid': 2, 'prednisolone': 2, 'progesterone receptor': 1, 'eribulin': 1, 'fulvestrant': 3, 'ec': 1, 'capecitabine': 1, 'docetaxel': 4, 'nivolumab': 3, 'anastrozole': 2, 'epirubicin': 5, 'cyclophosphamide': 6, 'fructose': 1, 'pertuzumab': 5, 'fluorouracil': 7, 'neosphere': 1, 'tryphaena': 1, 'imatinib': 4, 'cholesterol biosynthesis': 1, 'epoxidase inhibitors': 1, 'antifungal': 1, 'chemotherapy(tc)and': 1, 'chemo': 2, 'bevacizumab': 4, 'fulvestrant)was': 1, 'gemcitabine': 1, 'nab - paclitaxel': 1, 'icg': 1, 'intratumorally': 1, 'photodynamic': 1, 'aromatase inhibitors': 1, 'cdk4/6 inhibitors': 1, 'glucocorticoid': 1, 'anthracycline': 1, 'progesterone receptor (pr membrane component': 1, 'progesterone receptor membrane component': 7, 'fpr2': 1, 'gpr37': 1, 'ccr5': 1, 'radioactive iodine ( radioactive iodine ) treatment increased markedly . radioactive iodine': 1, 'radioactive iodine treatment': 2, 'radioactive iodine ( yes v no or unknown ) using poisson regression among > /= 5-': 1, 'radioactive iodine treatment ( 45': 1, 'nonsignificantly': 1, 'radioactive iodine': 2, 'carboplatin': 3, 'blebbing': 1, 'psychotropics': 1, 'doxycycline': 1, 'citrate ions': 1, 'anticancer compounds': 1, 'psn': 1, 'cancer': 1, 'progesterone receptor ) receptor (pr - negative human breast cancer (bc . here , we show that reverting the high lip': 1, 'nmyc': 1, 'psycinfo': 1, 'hormone binding globulin ( sex hormone binding globulin )': 1, 'hormone binding globulin': 1, 'hormone binding globulin by suppression status . conclusions : there were no differences in fe2 but significantly lower e2 and higher sex hormone binding globulin among women with hiv versus without hiv . further research is merited in a large contemporary sample': 1, 'adjuvant': 1, 'bisphosphonate': 6, 'ibandronate': 1, 'zoledronic acid': 1, 'glutathione peroxidase': 2, 'irgd': 1, 'ferroptosis': 1, 'postmastectomy': 1, 'clinicopathological': 1, 'progesterone receptor (pr ( pgr ) status , in which er-/pgr + tended to present the worst prognosis . conclusion : this study revealed profound heterogeneity associated with hazard ratios status in the clinical outcomes of human epidermal growth factor receptor 2 - positive breast cancer (bc regarding clinicopathological': 1, 'ado - trastuzumab emtansine ( t - dm1 )': 1, 'monoclonal antibody': 1, 'microtubule inhibitor emtansine': 1, 'l1cam': 1, 'shrna': 1, 'oncomine': 1, 'aurein': 1, 'aromatase inhibitors ( aromatase inhibitors )': 1, 'nsaids': 1, '2012.purpose': 1, '12,907': 1, 'chop': 1, 'pampk': 2, 'grp78': 2, 'bax': 2, 'valrubicin': 1, 'antibiotics': 1, 'steroids': 2, 'leuprorelin': 1}, 'cancer': {'urapidil': 1, 'bisphosphonates': 1, 'denosumab': 1, 'actinomyces': 4, 'chemotherapy': 44, 'intratumoral': 1, 'corynoline': 1, 'acetylcorynoline': 2, 'rapamycin': 4, 'mercapturic acid': 1, 'multivalency': 1, 'linifanib': 1, 'cytosponge': 1, 'rosetrees': 1, 'stoneygate': 1, 'cisplatin': 11, 'gemcitabine': 9, 'pemetrexed': 2, 'bevacizumab': 4, 'demethylase': 6, 'higenamine': 1, 'hdac': 1, 'magl': 1, 'pharmacokinetics': 1, 'chemoradiotherapy': 4, 'carboplatin': 5, 'paclitaxel': 11, 'trametinib': 2, '-1/1/2/3': 1, 'pd-1 monoclonal antibody treatment . collectively , these data demonstrate that ifitm4p may serve as a new therapeutic target in blockage of oral': 1, 'pd-1 monoclonal antibody can be an efective reagent': 1, 'chemo': 1, 'docetaxel': 5, 'nab - paclitaxel against b16f10': 1, 'paeoniaceae': 1, 'p70s6 k signaling': 1, 'imidazoquinoline agonists': 1, 'covalent inhibitor': 1, 'gsh': 1, 'cytotoxic': 1, 'photothermal': 5, 'iron oxide': 1, 'chemotherapies': 1, 'chloroisopropyl': 2, 'phosphate': 1, 'organophosphate': 1, 'mek inhibitor ( mek inhibitor': 1, 'mek inhibitor / anti - pd - l1 therapy (pdt': 1, 'optn': 1, 'chemokine ligand': 1, 'lr': 1, 'rbc folate': 3, 'rbc': 1, 'rbc folate concentration': 1, 'normal folate status is important for reducing the risk of cervical intraepithelial': 1, 'propofol': 4, 'sevoflurane': 2, 'anesthesia': 1, 'icnb': 3, 'asa': 1, 'anesthetics': 1, 'estradiol': 1, 'testosterone': 1, 'progesterone': 1, 'nicotine': 2, 'imatinib': 3, 'erlotinib': 1, 'nilotinib': 1, 'dasatinib': 3, 'sorafenib': 1, 'scopolamine': 1, 'allyl isothiocyanate ( allyl isothiocyanate )': 1, 'allyl isothiocyanate': 4, 'allyl isothiocyanate action': 1, 'intragastrically': 1, 'irrespectively': 1, 'allyl isothiocyanate considerably lowered thyroid hormones ( ft4 , ft3 )': 1, 'allyl isothiocyanate at': 2, 'hydroxybutyric acid': 1, 'insulin': 1, 'blood insulin': 1, 'atezolizumab': 1, 'nomogram': 1, 'akt inhibitor': 1, 'foundationone': 1, 'taxane': 2, 'cobas': 1, 'osimertinib': 1, 'pupose': 1, 'multitesting': 1, 'msh6': 1, 'msh2': 1, 'nctn': 1, 'amino acid ( amino acid': 1, 'amino acid': 1, 'anticoagulation': 1, 'glyco disulfide acted as reducing and capping agents of gold ions': 1, 'o2': 1, 'crispr': 1, 'phosphodiesterase-5 inhibitors': 1, 'metformin': 11, 'lewis acid as additive': 1, 'trifluridine': 2, 'tipiracil': 2, 'ftd': 1, 'fluorouracil': 2, 'deregulation': 1, 'oxaliplatin': 3, 'supplementation': 1, 'ceramides': 1, 'fdi': 1, 'neoadjuvant immunotherapy': 1, 'nivolumab': 4, 'ipilimumab': 2, 'ccrt': 1, 'iqr': 2, 'pembrolizumab': 5, 'lignans': 1, 'adenosine triphosphate': 2, 'linalool oxide': 1, 'fatty acid biosynthesis': 1, 'phosphatidic acid': 1, 'cholesteryl esters distinguished amino acid': 1, 'suvmean': 1, 'flavonoids chemical': 1, 'superoxide anion radicals': 1, 'arthrocnemum indicum (willd.) moq. indicum shoot ethanolic extract': 1, 'kaempferol': 1, 'ascorbic acid': 1, 'isavuconazole': 6, 'mucormycosis': 1, 'antifungal': 2, 'corticosteroids': 1, 'tamoxifen': 16, 'hydroethanolic': 2, 'nitric oxide': 1, 'malondialdehyde': 1, 'glutathione peroxidase ( gsh - px )': 1, 'indole alkaloids': 1, 'diketopiperazines': 1, 'characella': 1, 'gnps': 1, 'cyanocobalamin': 1, 'vitamin b12': 1, 'undaria': 1, 'lerdsin': 1, 'mirtazapine': 7, 'chemoradiation': 1, 'niraparib': 2, 'haematological': 1, 'trastuzumab': 3, 'pd-1': 5, 'pd-1 inhibitors in combination': 1, 'pd-1 inhibitor': 1, 'adjuvant chemotherapy': 1, 'neoadjuvant chemotherapy': 1, 'irinotecan': 1, 'akaike': 1, 'alectinib': 2, 'cbdca': 3}, 'human immunodeficiency virus': {'praziquantel': 1, 'pneumocystosis': 1, 'fresh frozen plasma ( fresh frozen plasma )': 1, 'red cell component composed': 1, 'fresh frozen plasma composed': 1, 'insulin': 6, 'urothelial': 1, 'chemotherapy': 7, 'pembrolizumab': 1, 'enfortumab vedotin': 3, 'docetaxel': 1, 'kisesa': 1, 'antibiotic': 4, 'pegylated': 4, 'doxorubicin': 5, 'penicillin': 1, 'transcriptase inhibitors ( nucleoside reverse transcriptase inhibitors': 1, 'ribonucleic acid': 2, 'corticosteroids': 2, 'tacrolimus': 1, 'compound trimethoprim - sulfamethoxazole ( smx - tmp )': 1, 'caspofungin': 3, 'blood': 1, 'nrp2': 2, 'lr': 7, 'methadone': 1, 'amino acid substitutions': 1, 'los alamos international database . results and discussion': 1, 'q54p': 1, 'reactogenicity': 1, 'microbicide': 1, 'tenofovir': 4, 'mtor inhibitors': 1, 'sfold': 1, 'ribonucleic acid structure web server )': 1, 'aor': 1, 'glycyrrhizinic acid ( glycyrrhizinic acid': 1, 'nicotinic acid': 1, 'biotarget': 1, 'qsar': 1, 'steroids': 5, 'cyclophosphamide': 2, 'coumarin': 2, 'prednisone': 3, 'foscarnet': 1, 'phosphoric acid in methanol': 1, 'rifampicin': 7, 'rifabutin': 3, 'pharmacokinetics': 1, 'isoniazid': 1, 'pyrazinamide': 1, 'ethambutol': 1, 'nucleoside inhibitors': 1, 'transcriptase inhibitors': 1, 'rilpivirine': 1, 'polylactic acid ( polylactic acid': 1, 'cypa': 1, 'tabsint': 1, 'otocalc': 1, 'ad5/35': 1, 'cgag': 1, 'darunavir': 2, 'human serum albumin (hsa ( deoxyribose nucleic acid dna )': 1, 'deoxyribose nucleic acid dna with the formation constants of 2.7 x 10(4 )': 1, 'ribonucleic acid ( guide rna )': 1, 'interferon - alpha , systemic corticosteroids': 1, 'rituximab': 1, 'r - chop ( rituximab ,': 1, 'vincristine': 1, 'prednisone).activation': 1, 'unani': 1, 'tibb': 1, 'antineoplastic': 1, 'transmembrane serine proteinase': 1, 'antifungal': 2, 'infliximab': 1, 'fcgamma': 3, 'doxycycline': 1, 'moxifloxacin': 1, 'ukhrul': 1, 'akaike': 1, 'immunosuppressive': 1, 'analgesics': 1, 'nonsteroidal': 1, 'immunosuppressive agents': 1, 'anticoagulants': 2, 'rivaroxaban': 1, 'apixaban': 1, 'dabigatran': 1, 'warfarin': 8, 'edoxaban': 9, 'psycinfo': 1, 'cinahl': 1, 'integrase inhibitor dolutegravir': 1, 'protease inhibitor - based antiretroviral therapy )': 1, 'ribonucleic acid viruses , compared to dsdna)': 1, 'coprescribed': 1, 'diclofenac': 1, 'antacids': 2, 'protease inhibitors': 1, 'zolpidem': 1, 'betamethasone': 1, 'loperamide': 1, 'telaprevir': 1, 'nitd008': 1, 'ribavirin': 1, 'pimodivir': 1, 'ribonucleic acid - binding family of proteins': 1, 'opioids': 2, 'dapivirine': 1, 'purine nucleotides': 1, 'lamivudine': 1, 'trimethoprim': 1, 'sulfamethoxazole': 2, 'imipenem': 1, 'cilastatin': 1, 'leu8': 1, 'neuropathogenesis': 1, 'lysophosphatidylcholines': 5, 'acylcarnitines': 4, 'volatilitytrend': 1, 'antibiotics': 2, 'corticosteroid': 1, 'trimethoprim - sulfamethoxazole ( sulfamethoxazole ) was administered to prevent pneumocystis pneumonia resulting from corticosteroid': 1, 'clindamycin': 1, 'azithromycin': 1, 'pyrimethamine': 1, 'sulfadiazine': 1, 'immunosuppressive therapies': 1, 'levofloxacin': 2, 'aminoglycosides': 1, 'carbapenems': 1, 'fluoroquinolones': 1, 'cephalosporins': 1}, 'infection': {'mrna vaccine': 1, 'coronavac': 3, 'karasek': 1, 'siegrist': 1, 'analgesia': 15, 'baclofen': 7, 'lpb': 1, 'morphine': 2, 'bupivacaine': 3, 'fentanyl': 2, 'alginate': 1, 'deoxynivalenol': 4, 'muc2': 1, 'immunotoxicity': 1, 'multivalency': 1, 'anesthetics': 1, 'immunoglobulins': 1, 'steroid': 3, 'antibiotics': 10, 'chlorhexidine': 11, 'antibiotic': 10, 'penicillin': 1, 'amino acid (ja alignment and phylogenetic analysis indicated that ontraf2 showed relatively low identify without (non-co other teleost traf2 proteins , without (non-co the exception of traf2s from epinephelus coioides': 1, '5.513mum': 1, 'interferon ( interferon )': 1, 'kermack': 3, 'mckendrick': 3, 'farnesyl transferase inhibitor ( farnesyl transferase inhibitor': 1, 'lonafarnib': 1, 'farnesyl transferase inhibitor': 2, 'antigenemia': 1, 'sociodemographics': 1, 'rbc folate': 3, 'rbc': 1, 'rbc folate concentration': 1, 'normal folate status is important for reducing the risk of cervical intraepithelial': 1, 'aecii': 1, 'carbapenems': 1, 'cephalosporins': 1, 'fluoroquinolones': 2, 'stimwave': 1, 'visual analog scale )': 1, 'dexamethasone': 3, 'potadoma': 1, 'scedosporium': 4, 'microsporum': 1, 'amoxicillin': 1, 'streptomycin': 1, 'ciprofloxacin': 1, 'ertapenem': 1, 'teta': 1, 'tetracycline': 1, 'dfra1': 1, 'mcr-4': 1, 'dextran sulfate sodium ( dextran sulfate sodium': 1, 'dextran sulfate sodium': 1, 'proventriculus': 1, 'cochrane': 1, 'paracentral': 1, 'covishield': 1, 'megakaryocyte': 1, 'heterodera': 1, 'ichinohe': 1, 'g3890': 1, 'g4549': 1, 'antifungal': 12, 'trimethoprim': 1, 'sulfamethoxazole ( tmp - smx': 1, 'clindamycin': 2, 'vitamin d': 2, 'procoagulant': 1, 'giessen': 1, 'epichloe': 1, 'antifungals': 1, 'nea23': 2, 'salicylic acid (ja ( salicylic acid )': 1, 'jasmonic acid (ja ( jasmonic acid )': 1, 'abscisic acid (ja ( abscisic acid )': 1, 'salicylic acid': 2, 'jasmonic acid': 2, 'abscisic acid': 2, 'cla97c05g081210': 1, 'cla97c04g071000': 1, 'cla97c10g198890': 1, 'jasmonate': 1, 'eortc': 1, 'conidia': 1, 'voriconazole': 1, 'pneumocystosis': 1, 'corticosteroids': 1, 'pharmacokinetics': 1, 'pharmacodynamics': 3, 'endonuclease inhibitor': 1, 'mitochondrial': 1, 'insulin': 3, 'sonneradon': 2, 'antiaging': 1, 'sulphated polysaccharides of red algae': 1, 'carrageenans': 1, 'embase': 2, 'cucurbitadienol': 1, 'chemotherapy': 1, 'valaciclovir': 1, 'foscarnet sodium hydrate': 1, 'intravitreal methotrexate ( methotrexate )': 1, 'methotrexate': 3, 'foscarnet': 1, 'intravitreal foscarnet': 1, 'immunoglobulin': 1, 'macrolides': 1, 'finland': 1, 'sweden': 1, 'ficleduovirus': 1, 'myoviridae': 1, 'cinahl': 1, 'lidocaine': 2, 'governments': 2, 'rituximab': 6, 'cyclophosphamide': 4, 'tenofovir': 1, 'tenofovir prodrug': 1, 'tenofovir disoproxil fumarate ( tenofovir-disoproxil-fumarate': 1, 'entecavir': 6, 'vedolizumab': 2, 'intratumoral': 1, 'rivaroxaban': 1, 'sedatives': 1, 'cladosporium': 1, 'hanoi': 1, 'lipids': 1, 'propofol': 2, 'kingella': 1, 'chemo': 5, 'mucosal': 2, 'subgingival': 4, 'red complex microorganisms': 1, 'periodontopathogens': 3, 'ameloblastomas': 2, 'antimicrobials': 1, 'porphyromonas': 1, 'aggregatibacter': 1, 'probiotics': 2, 'coronaviruses': 1, 'gellan': 1, 'sprayability': 1, 'carrageenan': 1}, 'hepatitis c': {'28,525': 1, 'red blood cells ( red blood cells': 1, 'nucleoside analogs': 1, 'ribonucleic acid viruses is very recent , despite ribonucleic acid viruses comprising some of the most damaging human pathogens ( e.g. ,': 1, 'sofosbuvir': 10, 'nucleoside analogs target the ribonucleic acid - dependent ribonucleic acid polymerase ( rna-dependent rna polymerase )': 1, 'ribonucleic acid viruses display a peculiar elaboration of the classical polymerase architecture that leads to their active site being caged': 1, 'nucleoside analogs as inhibitors': 1, 'fresh frozen plasma ( fresh frozen plasma )': 1, 'red cell component composed': 1, 'fresh frozen plasma composed': 1, 'antihistamines': 3, 'antibiotic': 6, 'antibiotics': 3, 'tamoxifen': 2, 'serm compounds': 1, 'antivirals': 15, 'nucleosides': 1, 'youden': 1, 'psychinfo': 1, 'lpc(18:0': 1, 'isocaproic acid': 1, 'taurocholic acid': 1, 'meropenem': 1, 'electrochemiluminescence': 5, 'nonselective beta - blockers ( or = 0.294': 1, 'blood': 1, 'velpatasvir': 4, 'glecaprevir': 2, 'biopharmaceutics': 1, 'verapamil': 3, 'coculture': 1, 'fibrogenesis': 2, 'ribonucleic acid independently suppressed hbv-': 1, 'hyaluronic acid ( hyaluronic acid': 1, 'hyaluronic acid': 1, 'opioid': 34, 'prescription opioid exposure status ( long - term vs prescription opioid - naive / acute )': 1, 'morphine': 2, 'flavonoid silymarin': 1, 'amanita': 1, 'anticancer': 1, 'silymarin compounds': 1, 'saudi': 1, 'arabia': 1, 'nicotinamide adenine dinucleotide ( nicotinamide adenine dinucleotide )': 1, 'nad+': 1, 'nicotinamide adenine dinucleotide ( nadh )': 1, 'nicotinamide adenine dinucleotide levels declined in skeletal muscle in association with human immunodeficiency virus infection and was exacerbated by hepatitis c virus (hcv and cytomegalovirus coinfection': 1, 'nicotinamide adenine dinucleotide': 2, 'coinfections': 1, 'nicotinamide adenine dinucleotide metabolites in skeletal muscle in association with viral coinfection': 1, 'pathogeneses': 1, 'tcell': 1, 'dichlorcyclizine': 3, 'fluoxazolevir': 2, 'ribonucleic acid': 3, 'embase': 1, 'scopus': 1, 'steroids': 2, 'cyclophosphamide': 1, 'opioids': 10, 'stimulants': 4, 'australian': 1, 'steatotest': 1, 'nashtest': 1, 'insulin': 1, 'aluminium hydroxide': 1, 'ribonucleic acid interference molecules': 1, 'checkpoint inhibitors': 1, 'elastography': 1, 'hccs': 3, 'unani': 1, 'tibb': 1, 'antineoplastic': 1, 'transmembrane serine proteinase': 1, 'fatal opioid': 1, 'fentanyl': 1, 'naloxone': 1, 'immunosuppressive': 1, 'analgesics': 1, 'nonsteroidal': 1, 'immunosuppressive agents': 1, 'antithyroid peroxidase [ atpo': 1, 'free thyroxine ( ft4 )': 1, 'thyroid medication': 1, 'covid-19.background': 1, 'nbnc': 2, 'ribavirin': 9, 'psycinfo': 1, 'cinahl': 1, 'interactions': 1, 'anticoagulants': 1, 'telaprevir': 1, 'nitd008': 1, 'pimodivir': 1, 'clethrionomys': 1, 'interferon alpha / beta receptor deficient c57': 1, 'ledipasvir': 1, 'sof': 1, 'deregulation': 1, 'methadone': 2, 'buprenorphine': 1, 'ribonucleic acid polymerases ( rna-dependent rna polymerase )': 1, 'nucleotide analogues': 1, 'sertraline': 1, 'syzgium': 1, 'rapamycin': 1, 'multikinase inhibitor': 1, 'sorafenib': 5, 'rapamycin inhibitor': 1, 'temsirolimus': 4, 'podocytopathies': 1, 'coinfected': 3, 'virologic': 1}, 'ulcerative colitis': {'glucagon': 2, 'ghrelin': 1, 'cholecystokinin': 2, 'mesalazine': 2, 'vedolizumab': 23, 'iron': 2, 'ferric': 1, 'ferinject': 1, 'metabolite taurine': 1, 'erysipelotrichaceae': 2, 'taurine': 1, 'betaine': 1, 'asa': 3, 'interval cholecalciferol administration': 1, 'infliximab': 65, 'cholecalciferol': 2, 'vitamin d': 3, 'chemotherapy(act)in': 1, 'oxaliplatin': 1, 'dextran sulfate sodium': 17, 'dextran sulfate sodium + wogonin ( 30 mg / kg / day )': 1, 'sulfasalazine': 4, "dextran sulfate sodium significantly reduced body weight , colon length , and increased inflammation in the colon . wogonin treatment prevented colonic ulceration , neutrophil infiltration , oxidative stress , pro - inflammatory cytokines , and histological changes . oxidative damage and inflammatory mediators ' elevation were also dramatically diminished by wogonin . wogonin activates apoptosis via inhibiting bcl-2 and augmenting bax , caspase-3 , and -9 expressions . wogonin downregulated the cox-2 and inos": 1, 'thiopurines': 4, 'methotrexate': 8, 'azathioprine': 9, 'caffeic acid phenethyl ester ( caffeic acid phenethyl ester )': 1, 'anticancer': 1, 'caffeic acid phenethyl ester on dextran sulfate sodium': 1, 'caffeic acid phenethyl ester to dextran sulfate sodium -': 1, 'caffeic acid phenethyl ester': 1, 'caffeic acid phenethyl ester treatment leads to the reduced expressions of intercellular adhesion molecules (vcam (': 1, 'caffeic acid phenethyl ester can potentially control inflammation in the colon and can be used as a therapy': 1, 'astaxanthin': 6, 'sodium alginate': 1, 'dextran sodium sulfate': 1, 'nitric oxide': 2, 'lactobacillaceae': 1, 'steroid': 28, 'berberine': 1, 'hyaluronic acid ( ha)-modified chitosan - guanidine - co2 nanoparticles ( ha - cg - co2@nps )': 1, 'corticosteroids': 14, 'corticosteroid': 6, 'mesalamine': 8, 'azoxymethane': 1, 'metaproteomic': 1, 'cortisone': 3, 'tacrolimus': 6, 'prednisolone': 4, 'calcineurin inhibitor': 1, 'trinitrobenzene sulfonic acid ( tnbs)/ethanol method': 1, 'metaboanalyst': 1, 'uplc': 1, 'arginine': 1, 'serine': 1, 'glyoxylate': 1, 'dicarboxylate': 1, 'amino acid metabolism': 1, 'plinear': 1, 'magnoliae': 1, 'trinitrobenzene sulfonic acid ( tnbs)-induced ulcerative colitis ( ulcerative colitis )': 1, 'tnbs': 1, 'probiotics': 8, 'akkermansia': 1, 'blautia': 1, 'allobaculum': 1, 'alloprevotella': 1, 'wilcoxon': 2, 'steroids': 15, 'thymectomy': 1, 'phenytoin': 6, 'hydrocortisone': 1, 'acetic acid': 1, 'ruxolitinib': 1, 'golimumab': 2, 'pharmacokinetics': 3, 'pharmacodynamics': 1, 'immunosuppressants': 1, 'adalimumab': 9, 'synbiotics': 3, 'gos': 1, 'dextran sulfate sodium -': 11, 'dextran sulfate sodium drink': 1, 'malondialdehyde': 5, 'nitric oxide ( nitric oxide': 1, 'terazosin': 2, 'budesonide': 3, 'immunomodulator': 1, 'mercaptopurine': 2, 'antibiotic': 3, 'systemic corticosteroid': 1, 'systemic corticosteroids': 1, 'antibiotics': 1, 'nsaid': 1, 'itraconazole': 1, 'opioid': 3, 'ustekinumab': 5, 'noviembre': 1, 'colombia': 1, 'tofacitinib': 3, 'allopurinol': 1, 'pump inhibitor': 5, 'valacyclovir': 1, 'torsemide': 1, 'losartan': 1, 'isoniazid': 1, 'prednisone': 3, 'ace': 3, 'albumin': 1, 'salicylates': 1, 'uceris': 1, 'vancomycin': 2, 'glucocorticoids': 1, 'blood insulin ( 18.41 + /- 11.88 vs 6.4 + /- 4.26': 1, 'blood insulin': 1, 'immunomodulators': 3, 'ozanimod': 25, 'ozanimod hcl': 4, 'janus kinase inhibitor': 2, 'europe': 1, 'japan': 1, 'dyyb': 4, 'methylprednisolone': 2, 'dyyb lacks monobasic sodium phosphate': 1, 'dibasic sodium phosphate': 1, 'antidepressants': 3, 'dofp': 1, 'neferine': 1, 'sddr': 1, 'anandamide': 1, 'agonists': 1, 'mrnas': 1, 'kinase inhibitors': 1, 'allosteric tyrosine kinase 2 inhibitor discovered': 1, 'p62': 1, 'ampk inhibitor compound c significantly reversed the anti - inflammatory effect of procyanidin': 1, 'ampk': 1, 'elabela': 2, 'pubmed': 1, 'cinahl': 1, 'embase': 2, 'tpn': 1, 'monocytosis': 1, 'ginsenoside': 4, 'lachnospiraceae': 1, 'dextran sulfate sodium developed severe mucosal colitis . anemone chinensis bunge aqueous': 1, 'lactobacillus reuteri': 1, 'lactobacillus': 1, 'bacteroidetes': 4, 'nicotine': 2, 'alpha7nachr antagonist': 1, 'jak2 inhibitor': 1, 'heparin': 2, 'aspirin': 1, 'anticoagulation': 1, 'paeonia': 1, 'paeoniae': 2, 'lactiflora': 1, 'dextran sodium': 1, 'opiate': 1, 'genecards': 1, 'chp2': 1, 'vitamin d receptor': 4, 'thymosin': 1, 'lymphoproliferative': 3, 'chemotherapy': 1, 'calcineurin inhibitors': 1, 'janus kinase inhibitor ( janus kinase inhibitor )': 1, 'lactic acid bacterium lactococcus lactis': 1, 'dextran sulfate sodium ( dextran sulfate sodium )': 2, 'metformin': 4, '3.546': 1, 'chimeric monoclonal anti - tnfalpha antibody , was administrated': 1, 'curcumin': 2, 'chemokines': 1, 'superoxide dismutase': 2, 'nucleic acid drugs': 3, 'dextran sodium sulfate ( dss)-induced mice and its potential mechanism in their brain . male c57bl/6 mice were treated with mesalazine and various doses': 1, 'saccharina': 1, 'dextran sulfate sodium treatment': 1, 'dextran sodium sulfate ( dextran sulfate sodium )': 1, 'dextran sulfate sodium concentration': 2, 'interdigitated': 1, 'pik3cd': 1, 'retinoic acid receptor - related orphan receptor - gamma t ( receptor-gamma t )': 1, 'butyrilcholinesterase inhibitor': 1, 'zwitterionic sulfonate': 3, 'zwitterionic carboxylate ( lzs)': 1, 'dextran sulfate sodium ( dextran sulfate sodium': 1, 'lzs': 1, 'zwitterionic carboxylate': 1, 'il-2': 3, 'cyclosporine': 1, 'balb': 1, 'wumei': 1}, 'depression': {'get.calm-move.on': 3, 'ionotropic glutamate receptor family': 1, 'psychotropics': 3, 'sloreta': 1, 'sevoflurane': 1, 'analgesic': 3, 'anesthetics': 1, 'isoflurane': 3, 'xysef': 1, 'berberine': 5, 'dopamine': 6, 'fluoxetine': 13, 'bbrl': 1, 'bbrm': 1, 'bbrh': 1, 'hydroxyindoleacetic acid': 1, 'antiretroviral': 2, 'methylene blue ( methylene blue )': 1, 'nitric oxide synthesis': 1, 'methylene blue': 1, 'methylene blue group (n=119 included 53 patients . in both groups , the numeric rating scale': 1, 'methylene blue group (n=119 were also respective significantly lower than that of the control group (n=119 at 3 months': 1, 'methylene blue group (n=119': 1, 'methylene blue injection': 1, 'methylene blue can significantly reduce pain intensity , improve patient lumbar function , pain - related depression and sleep quality , increase total effective rate with no severe adverse side effects.(1 )': 1, 'analgesia': 1, 'morphine': 5, 'benzodiazepine': 1, 'opioid': 6, 'worklife': 4, 'stigmatising': 1, 'aripiprazole': 3, 'vrs': 1, 'lidocaine': 5, 'prozac': 1, 'talbinah': 1, 'norepinephrine': 5, 'noradrenaline': 1, 'bidirectionality': 1, 'psycinfo': 1, 'subanaesthetic': 1, 'ketamine': 11, 'opioids': 3, 'probiotics': 1, 'bimuno': 2, 'anesthesia': 1, 'propofol': 2, 'rocuronium bromide': 1, 'chronic opioid': 1, 'chronic opioid administration': 1, 'reuptake inhibitor ( ssri )': 1, 'breastfeeding': 1, 'psychedelics': 3, 'antipsychotics': 1, 'dopamine blocker': 1, 'intracerebroventricular': 1, 'cysteine protease': 1, 'pancreaticoduodenectomy': 1, 'vasoactive medications': 1, 'metabotropic glutamate receptors ( mglur1 and mglur5': 1, 'synaptopodin': 1, 'zentralschweiz': 1, 'cinahl': 3, 'scopus': 1, 'toronto': 1, 'antidepressants': 1, 'dextromethorphan': 1, 'bupropion': 1, 'ansofaxine hydrochloride': 1, 'nitrous oxide': 1, 'psilocybin': 1, 'ayahuasca': 1, 'embase': 1, 'covidence': 1, 'beta - blockers': 2, 'beta - blocker use': 1, 'beta - blocker ( adjusted or [ adjusted odds ratio ]': 1, 'propranolol': 3, 'protopathic': 1, 'beta - blocker therapy': 1, 'folic acid': 25, 'folic acid (': 2, 'folic acid )': 1, 'chemotherapy': 8, 'shfsp': 1, 'neurorehabilitation': 1, 'uric acid': 1, 'intrahippocampal': 1, 'aav': 1, 'receptor agonist sumatriptan': 1, 'serotonin': 2, 'sumatriptan': 2, 'bacopa': 7, 'betulinic acid': 1, 'asiatic acid': 1, 'quercetin': 1, 'dysregulate': 1, 'analgesics': 2, 'dilute lactic acid': 1, 'nonsteroidal anti - inflammatory drug ( nonsteroidal anti-inflammatory drug ) ketoprofen ( 10 mg / kg )': 1, 'vietnam': 1, 'mentalization': 1, 'turkish': 1, 'breathlessness': 5}, 'fibrosis': {'organophosphorus pesticides ( organophosphorus pesticides )': 1, 'organophosphorus pesticides': 4, 'ifngamma': 1, 'il-2': 1, 'immunostaining': 1, 'immunoblotting': 1, 'tissue inhibitor of matrix metalloproteinase': 1, 'esculetin': 1, 'albuminuria': 1, 'beta receptor i ( tgf - beta r1 , also known as activin - like kinase 5 or alk5 ) plays a significant role in the pathogenesis of multiple diseases such as malignant tumors and tissue fibrosis . specific inhibition of alk5': 1, 'fibrogenesis': 4, 'elastography': 1, 'amino acid': 1, 'mmp8': 1, 'eotaxin': 1, 'tgfrbeta': 1, 'mmp2': 1, 'estradiol': 2, 'corn oil': 1, 'ctgf': 1, 'mesalazine': 2, 'embase': 1, 'scopus': 1, 'bleomycin': 3, 'nonpersistent': 2, 'dawley': 1, 'steroid': 6, 'hyaluronic acid ( hyaluronic acid )': 1, 'hyaluronic acid': 4, 'piiip': 1, 'ocimum': 4, 'dangshen erling decoction ( dangshen erling decoction': 1, 'dangshen erling': 2, 'dangshen erling decoction': 4, 'microplates': 1, 'complexation': 1, 'fatty acid oxidation ( fatty acid oxidation )': 1, 'fatty acid oxidation': 1, 'rois': 1, 'hypochlorous acid': 1, 'cytoscape': 1, 'cytohubba': 1, 'mcode': 1, 'maresin': 2, 'protectin': 2, 'cyclophosphamide': 4, 'mineralocorticoid receptor antagonists is therapeutic for chronic skeletal muscle pathology in duchenne muscular dystrophy ( duchenne muscular dystrophy ) mouse models': 1, 'myofiber mineralocorticoid receptor knockout improves skeletal muscle force': 1, 'keratocytes': 2, 'vdr agonist': 1, 'immunohistochemical': 1, 'mxene': 1, 'histopathological': 1, 'tobramycin': 8, 'ceftazidime': 7, 'hypermutable': 1, 'mictob': 2, 'miccaz': 1, 'antibiotic': 4, 'tamoxifen': 1, 'rapamycin': 3, 'mesangial cells': 1, 'adalimumab': 1, 'malondialdehyde': 5, 'gadolinium': 1, 'immunometabolite': 1, 'blood insulin': 1, 'streptozotocin': 5, 'microg': 1, 'corticosteroids': 2, 'azathioprine': 1, 'rituximab': 1, 'antibiotics': 12, 'heparan sulphate': 1, 'glycocalyx': 2, 'heparan sulfate ( heparan sulfate ) chains at the level of the proteoglycans': 1, 'syngeneic': 1, 'ethylene deoxyuridine ( ethylene deoxyuridine )': 1, 'hydroxyproline': 1, 'sertuercept': 3, 'bile acid': 3, 'chenodeoxycholic acid': 2, 'deoxycholic acid , glycocholic acid , glycochenodeoxycholic acid': 1, 'glycodeoxycholic acid , taurocholic acid': 2, 'taurochenodeoxycholic acid': 2, 'taurodeoxycholic acid': 1, 'taurolithocholic acid': 1, 'cholic acid': 1, 'deoxycholic acid , ursodeoxycholic acid': 1, 'glycocholic acid , glycochenodeoxycholic acid': 1, 'taurodeoxycholic acid , taurolithocholic acid , tauroursodeoxycholic acid': 1, 'forsythiaside': 5, 'bax': 1, 'prednisolone': 1, 'pinellia': 1, 'metformin': 1, 'apolipoprotein': 5, 'ziqi ruangan': 2, 'colchicine': 3, 'intragastric': 1, 'ruangan': 2, 'ejp': 1, 'smurf1': 7, 'pten': 1, 'chitinase': 4, 'cholangiopathies': 1, 'perflubutane': 1, 'contrast': 1, 'cocaethylene': 1, 'adipomastia': 1, 'hydrocortisone': 1, 'solumedrol': 1, 'transcriptional': 2, 'fatty acid metabolism': 1, 'chemoradiotherapy': 5, 'durvalumab': 3, 'cascn': 1, 'f508del': 6, 'chloride ion concentrations': 1, 'polyethylene glycol ( polyethylene glycol ) ( au@pei@peg )': 1, 'mc - lr were administrated': 1, 'mc - lr at 0 , 0.01 , 0.1 , 1 and 10 microm. mc - lr exposure caused mitochondrial dna ( mitochondrial dna ) leakage which was detected by qpcr andimmunofluorescence staining . subsequently , mitochondrial dna leakage activated cgas - sting signaling , leading to elevated production of inflammatory cytokines tnf - alpha in mouse ovarian granulosa cells': 1, 'methanol': 1, 'cajanus': 1, 'silymarin': 2, 'spectrophotometrically': 1, 'methanol extract cajanus': 1, 'fatty acid': 1, 'estrogens': 1, 'tetrabromobisphenol': 2, 'insulin': 3, 'dextran sulfate sodium': 1, 'prp': 5, 'minoxidil': 5, 'agonists': 1, 'glucagon': 3, 'receptor agonists': 3, 'lanifibranor': 1, 'trametinib': 3, 'youden': 1, 'meropenem': 4, 'cefiderocol': 1, 'ciprofloxacin': 3, 'chemotherapy': 1, 'bevacizumab': 6, 'pigf': 1}, 'spondylarthritis': {'glucocorticoids': 5, 'spondylarthritis': 247, 'rheumatoid': 3, 'rituximab': 3, 'nonsteroidal': 7, 'steroids': 1, 'polymyalgia': 1, 'b=-11.14': 1, 'methotrexate': 12, 'infliximab': 26, 'analgesic': 3, 'scopus': 3, 'spondyloarthritis': 12, 'cochrane databases': 1, 'il-17a inhibitor ( il-17a inhibitor': 1, 'secukinumab': 1, 'il-17a inhibitor': 2, 'ixekizumab': 2, 'pharmacokinetics': 1, 'etanercept': 9, 'immunomodulation': 1, 'berlin': 2, 'enterogenic': 1, 'axial spondylarthritis': 1, 'analgesics': 6, 'opioids': 11, 'nonsteroidal anti - inflammatory drugs ( nsaid)/coxibs were prescribed from 35': 2, 'systemic glucocorticoids ( glucocorticoids )': 1, 'cinahl': 3, 'entheseal': 3, 'systemic glucocorticoids in spondylarthritis ( 364 patients )': 1, 'prednisolone': 2, 'pustulosis': 2, 'antibiotic': 2, 'uveitis': 1, 'hydroxychloroquine': 1, 'betamethasone': 1, 'enteropathic spondylarthritis': 1, 'plaquenil': 1, 'adaption': 1, 'tocilizumab': 3, 'lidocaine': 2, 'triamcinolone': 2, 'oswestry': 1, 'extravertebral': 1, 'comorbidities': 1, 'curcumin': 2, 'saffron supplementation . garlic , ginger , cinnamon , or saffron supplementation': 1, 'hepatomegalia': 1, 'ngf': 1, 'bdnf': 3, 'rabbit - spondylarthritis': 1, 'antitnf': 1, 'adalimumab': 5, 'embase': 3, 'interleukin antagonists': 1, 'enteropathic': 1, 'enthesopathy': 2, 'colchicine': 1, 'vedolizumab': 4, 'torg': 1, 'immunohistopathogenesis': 1, 'steroid': 3, 'il-8': 1, 'hscrp': 1, 'jaks inhibitors': 1, 'upadacitinib': 1, 'visual analogue scale )': 1, 'chalder': 1, 'ianalumab': 1, 'dermatomyositis': 1, 'sacroiliitis': 1, 'serositis': 1, 'dialister': 1, 'collinsella': 1, 'nsaids': 8, 'univariate': 1, 'golimumab': 1, 'biologicals': 1, 'nonrheumatologists': 1, 'roentgenologic': 1, 'pa.background': 1, 'antirheumatic': 1, 'canada': 3, 'confirmed active spondylarthritis': 1, 'antibiotics': 4, 'sulfasalazine': 1, 'axial spondylarthritis - substudy : a total': 1, 'krgiltlky': 1, 'srywairtr': 1, 'prednisone': 2, 'nilotinib': 1, 'antifungal': 1, 'osteoclastic': 1, 'osteoblastic': 1, 'corticosteroids': 8, 'vitamin d': 1, 'vitamin d winter': 1, 'vitamin d3': 1, 'gothenburg': 1, 'sweden': 1, 'corticosteroid': 2, 'spondyloarthropathy': 2, 'atlantoaxial': 3, 'bisphosphonates': 1, 'resorptive': 1, 'opioid': 5, 'amed': 1, 'proquest': 1, 'headings': 1, 'enteropathic spondylarthritis . progranulin is a secreted protein with strong anti - inflammatory effects , believed to be mediated by the direct inhibition of tumor necrosis factor receptors': 1, 'enteropathic seronegative spondylarthritis )': 1, 'il-1 receptor antagonist': 2, 'il-1 receptor antagonist ( 16.9': 1}, 'infections': {'alginate': 1, 'antimicrobials': 2, 'crispr': 4, 'protospacers': 2, 'protospacer': 1, 'retropharyngeal': 1, 'fluconazole': 4, 'chlorhexidine': 13, 'antibiotics': 31, 'vancomycin': 2, 'linezolid': 7, 'levofloxacin': 1, 'antibiotic': 31, 'proteomes': 1, 'cgrgt1': 1, 'praziquantel': 1, 'intramuscular': 1, 'penicillin': 4, 'alpha agonist sedative': 1, 'supersede': 1, 'carbapenems': 3, 'cephalosporins': 1, 'fluoroquinolones': 1, 'duration': 1, 'spinosad': 1, 'antiseizure medication': 1, 'taiwan': 1, 'lactic acid dehydrogenase ( lactic acid dehydrogenase )': 1, 'isavuconazole': 7, 'mucormycosis': 2, 'antifungal': 11, 'pneumocystosis': 2, 'cryptococcosis': 1, 'voriconazole': 1, 'corticosteroids': 1, 'scedosporium': 16, 'pharmacokinetics': 1, 'pharmacodynamics': 2, 'astaxanthin': 4, 'fucoxanthin': 2, 'anticancer': 1, 'finland': 1, 'sweden': 1, 'ficleduovirus': 1, 'myoviridae': 1, 'red blood cell units': 1, 'rituximab': 10, 'cyclophosphamide': 6, 'vedolizumab': 4, 'mycophenolate mofetil': 1, 'sedatives': 1, 'colistin': 1, 'haemoproteus': 1, 'periodontopathogens': 1, 'insulin': 1, 'chemo': 1, 'diamine fluoride ( silver diamine fluoride': 1, 'silver diamine fluoride at baseline while school two received silver diamine fluoride': 1, 'diamine fluoride': 1, 'porphyromonas': 1, 'aggregatibacter': 1, 'probiotics': 2, 'nucleoside analogs': 1, 'sofosbuvir': 1, 'nucleoside analogs target the ca-hiv-rna - dependent ca-hiv-rna polymerase ( rna-dependent rna polymerase )': 1, 'nucleoside analogs as inhibitors': 1, 'dengvaxia': 1, 'tlr6': 2, 'macrophylla': 2, 'hoffmani': 1, 'acalypha': 1, 'hoffmanii': 1, 'scopus': 1, 'embase': 1, 'amphotericin': 2, 'packed red blood cell': 1, 'frozen plasma transfusions': 1, 'il-8': 3, 'royal jelly': 1, 'il-2': 1, 'agalactiae': 1, 'hyaluronic acid': 1, 'chondroitin sulfate': 2, 'meropenem': 4, 'imipenem': 3, 'aztreonam': 1, 'vitamin stores': 1, 'hemostatics': 1, 'immunosuppressants': 1, 'steroids': 1, 'corticosteroid': 1, 'autophagosome': 1, 'osteoarticular': 1, 'dextran sulfate sodium': 1, 'etoposide': 2, 'blood': 1, 'ssi': 2, 'cilastatin': 2, 'ertapenem': 1, 'hypochlorous acid': 1, 'doxycycline': 2, 'mwachinga': 1, 'dumbule': 1, 'falciparum': 2, 'cutibacterium avidum': 2, 'ceftriaxone': 1, 'ceftazidime': 2, 'antifungals': 1, 'oseltamivir': 1, 'iav.hiv-1': 1, 'integrase inhibitors': 1, 'ustekinumab': 1, 'cytoscape': 1, 'cytohubba': 1, 'mcode': 1, 'ivermectin': 1, 'albendazole': 1, 'wuchereria': 1, 'tenofovir disoproxil fumarate ( truvada ) prescription': 1, 'raltegravir': 1, 'hila': 1, 'serovar': 1, 'gentamicin': 1, 'tetracycline': 2, 'nitrofurantoin': 1, 'trimethoprim': 1, 'thiol peroxidase ( nthi 0907 )': 1, 'insertionally': 1, 'hydrogen peroxide': 1, 'zirconium phosphate carboxyaminophosphonates ( zirconium phosphate carboxyaminophosphonates )': 1, 'sodium magnesium chlorophyllin ( chl , approved as food additive': 1, 'fragaria': 1, 'polyaspartic acid': 1, 'sodium magnesium chlorophyllin in combination with edta and b17 - 0024 could serve as effective and safe photofungicides': 1, 'retinoic acid - inducible gene i ( rig - i )': 1, 'vasopressors': 1, 'daptomycin': 1, 'oxacillin': 5, 'clindamycin': 4, 'rnaiii': 2, 'mrna': 1, 'aroq': 2, 'amino acid': 1, 'agra': 1, 'nitric oxide': 1, 'hxui': 1, 'alwafi': 1, 'araco': 1, 'amoxicillin': 1, 'azithromycin': 1, 'carbapenem': 1, 'archosargus': 1, 'henneguya': 1}}

